Evogenix to develop anti-cancer antibody

10th Apr 2006, 08:20 GMT

Sydney-based drug company Evogenix has made an agreement with the University of Massachusetts Medical School (UMMS) to develop an anti-cancer antibody, which it says has large market potential.Under the deal, Evogenix will apply its technologies to rapidly advance the hamster antibody DMF10, which has shown evidence of activity against lung cancer and melanoma.